COMPOSITION:
Active principle
1 capsule contains: 6 mg of lyophilized bacterial lysates of Escherichia coli.
INDICATIONS/POSSIBILITIES OF USE:
Immunotherapy Prevention of recurrent lower urinary tract infections. Co-medication in the treatment of acute urinary tract infec¬tions.
Posology and method of administration Preventive treatment and/or consolidation therapy:
1 capsule daily on an empty sto¬mach, for 3 consecutive months.
TREATMENT DURING ACUTE EPISODES:
1 capsule daily on an empty stomach as co-medication to conventional antimicrobial therapy, until disappearance of the symptoms but for at least 10 consecutive days.